02 Oct 2008
People with Type 2 diabetes who require insulin to control their levels of blood glucose can use either the chemical from humans or a synthetic version which is similar in structure, according to a study.
Staff from US academic institution Johns Hopkins Hospital in Baltimore examined a number of clinical studies regarding the effectiveness and safety or premixed insulin analogues in comparison to other anti-diabetes agents in adults with the condition.
According to the report, published in the Annals of Internal Medicine journal, premixed insulin analogues provided tighter glucose control than long-acting and non-insulin agents.
Occurrence of episodes where people had too low an amount of glucose in their blood - hypoglycaemia - was similar in the analogues and human insulin.
"There is no difference between premixed human insulin and premixed insulin analogues," Dr Rehan Qayyum, from the organisation, told Reuters Health.
According to the research team, studies with a longer follow-up are now required to see whether the effects of the analogues are sustainable in the long term.
Click here to visit the Diabetes Quick Guide
Delicious
Reddit
Facebook
StumbleUpon